Beiersdorf stock slips 1.04% to EUR 84.75 premarket
Published on 11/06/2026 at 08:46 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSBeiersdorf faces mixed operating signals
- Third-quarter organic sales fell 1.3 percent, while the Consumer division declined 0.7 percent.
- Nivea sales dropped 4.9 percent, but Derma sales rose 10.6 percent and La Prairie gained 8.5 percent.
- Management maintained its 2026 guidance as HSBC downgraded the stock to hold and cut its price target to EUR 88 from EUR 90.
Beiersdorf stock traded at EUR 84.75 on Lang & Schwarz at 08:41 CET on Friday, November 6, 2026, 1.04 percent below the Xetra close of Thursday, November 5, 2026, at EUR 85.64. The premarket indication places the shares below the previous Xetra session after a mixed operating update.
Mixed signals across key brands
Beiersdorf reported third-quarter organic sales down 1.3 percent. Consumer division sales fell 0.7 percent, with Nivea declining 4.9 percent, including a 170-basis-point impact from a commercial dispute in Russia. Management said the dispute had been resolved and normal sales should resume in the fourth quarter.
Derma sales increased 10.6 percent and La Prairie sales rose 8.5 percent, while Healthcare gained 5.7 percent. Tesa sales fell 4.3 percent as electronics supply shortages weighed on the business. Beiersdorf maintained its 2026 guidance, although supply constraints remain a margin challenge for Tesa.
HSBC downgraded Beiersdorf to hold from buy and lowered its price target to EUR 88 from EUR 90, citing slower Nivea shopper sales and limited scope for margin improvement. The bank also reduced its 2027 earnings-per-share forecast to EUR 4.17 from EUR 4.22.
Investors can follow the real-time quote of Beiersdorf stock for the latest trading indication.
The broader market context is available in the latest DAX market reports.
More news and analyses on Beiersdorf stock provide further coverage of the company and its brands.
